Bank of New York Mellon’s Harvard Bioscience HBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $62.9K | Hold |
10,230
| – | – | ﹤0.01% | 4224 |
|
|
2026
Q1 | $49.8K | Sell |
10,230
-2,392
| -19% | -$13.4K | ﹤0.01% | 4143 |
|
|
2025
Q4 | $84.4K | Hold |
12,622
| – | – | ﹤0.01% | 4113 |
|
|
2025
Q3 | $55.3K | Hold |
12,622
| – | – | ﹤0.01% | 4125 |
|
|
2025
Q2 | $56K | Sell |
12,622
-8,333
| -40% | -$34.8K | ﹤0.01% | 4083 |
|
|
2025
Q1 | $119K | Hold |
20,955
| – | – | ﹤0.01% | 3982 |
|
|
2024
Q4 | $442K | Sell |
20,955
-2,053
| -9% | -$47.2K | ﹤0.01% | 3587 |
|
|
2024
Q3 | $619K | Sell |
23,008
-4,456
| -16% | -$131K | ﹤0.01% | 3396 |
|
|
2024
Q2 | $783K | Buy |
27,464
+3,151
| +13% | +$111K | ﹤0.01% | 3330 |
|
|
2024
Q1 | $1.03M | Sell |
24,313
-648
| -3% | -$29.1K | ﹤0.01% | 3134 |
|
|
2023
Q4 | $1.34M | Buy |
24,961
+2,261
| +10% | +$102K | ﹤0.01% | 3039 |
|
|
2023
Q3 | $976K | Buy |
22,700
+276
| +1% | +$12.7K | ﹤0.01% | 3163 |
|
|
2023
Q2 | $1.23M | Buy |
22,424
+8,969
| +67% | +$492K | ﹤0.01% | 3085 |
|
|
2023
Q1 | $565K | Hold |
13,455
| – | – | ﹤0.01% | 3431 |
|
|
2022
Q4 | $373K | Sell |
13,455
-2,875
| -18% | -$70.9K | ﹤0.01% | 3697 |
|
|
2022
Q3 | $419K | Sell |
16,330
-473
| -3% | -$15.6K | ﹤0.01% | 3666 |
|
|
2022
Q2 | $605K | Sell |
16,803
-9,828
| -37% | -$444K | ﹤0.01% | 3470 |
|
|
2022
Q1 | $1.65M | Buy |
26,631
+1,816
| +7% | +$107K | ﹤0.01% | 3040 |
|
|
2021
Q4 | $1.75M | Buy |
24,815
+2,883
| +13% | +$205K | ﹤0.01% | 3072 |
|
|
2021
Q3 | $1.53M | Buy |
21,932
+1,597
| +8% | +$127K | ﹤0.01% | 3162 |
|
|
2021
Q2 | $1.69M | Buy |
20,335
+4,559
| +29% | +$323K | ﹤0.01% | 3104 |
|
|
2021
Q1 | $862K | Buy |
15,776
+4,679
| +42% | +$228K | ﹤0.01% | 3417 |
|
|
2020
Q4 | $476K | Sell |
11,097
-241
| -2% | -$8.99K | ﹤0.01% | 3642 |
|
|
2020
Q3 | $341K | Buy |
11,338
+145
| +1% | +$4.88K | ﹤0.01% | 3668 |
|
|
2020
Q2 | $347K | Buy |
11,193
+9,790
| +698% | +$264K | ﹤0.01% | 3645 |
|
|
2020
Q1 | $31K | Hold |
1,403
| – | – | ﹤0.01% | 4018 |
|
|
2019
Q4 | $43K | Hold |
1,403
| – | – | ﹤0.01% | 4123 |
|
|
2019
Q3 | $43K | Hold |
1,403
| – | – | ﹤0.01% | 4135 |
|
|
2019
Q2 | $28K | Sell |
1,403
-9,587
| -87% | -$281K | ﹤0.01% | 4169 |
|
|
2019
Q1 | $473K | Sell |
10,990
-76
| -0.7% | -$2.75K | ﹤0.01% | 3582 |
|
|
2018
Q4 | $352K | Buy |
11,066
+801
| +8% | +$31.6K | ﹤0.01% | 3647 |
|
|
2018
Q3 | $539K | Sell |
10,265
-1,614
| -14% | -$90.6K | ﹤0.01% | 3615 |
|
|
2018
Q2 | $636K | Buy |
11,879
+7,662
| +182% | +$392K | ﹤0.01% | 3503 |
|
|
2018
Q1 | $211K | Buy |
4,217
+578
| +16% | +$25.9K | ﹤0.01% | 3919 |
|
|
2017
Q4 | $120K | Sell |
3,639
-44
| -1% | -$1.49K | ﹤0.01% | 4052 |
|
|
2017
Q3 | $138K | Hold |
3,683
| – | – | ﹤0.01% | 3942 |
|
|
2017
Q2 | $94K | Sell |
3,683
-116
| -3% | -$2.87K | ﹤0.01% | 4039 |
|
|
2017
Q1 | $99K | Buy |
3,799
+116
| +3% | +$3.34K | ﹤0.01% | 4033 |
|
|
2016
Q4 | $113K | Sell |
3,683
-223
| -6% | -$5.67K | ﹤0.01% | 4011 |
|
|
2016
Q3 | $106K | Sell |
3,906
-1,119
| -22% | -$31.1K | ﹤0.01% | 4025 |
|
|
2016
Q2 | $144K | Sell |
5,025
-6,192
| -55% | -$197K | ﹤0.01% | 3974 |
|
|
2016
Q1 | $338K | Buy |
11,217
+149
| +1% | +$4.22K | ﹤0.01% | 3596 |
|
|
2015
Q4 | $384K | Buy |
11,068
+129
| +1% | +$4.41K | ﹤0.01% | 3631 |
|
|
2015
Q3 | $413K | Sell |
10,939
-2,871
| -21% | -$134K | ﹤0.01% | 3666 |
|
|
2015
Q2 | $787K | Buy |
13,810
+9,627
| +230% | +$548K | ﹤0.01% | 3466 |
|
|
2015
Q1 | $243K | Hold |
4,183
| – | – | ﹤0.01% | 3843 |
|
|
2014
Q4 | $237K | Hold |
4,183
| – | – | ﹤0.01% | 3849 |
|
|
2014
Q3 | $171K | Sell |
4,183
-804
| -16% | -$37K | ﹤0.01% | 3925 |
|
|
2014
Q2 | $227K | Sell |
4,987
-8,437
| -63% | -$355K | ﹤0.01% | 3804 |
|
|
2014
Q1 | $636K | Sell |
13,424
-1,084
| -7% | -$49.3K | ﹤0.01% | 3494 |
|
|
2013
Q4 | $682K | Sell |
14,508
-8,920
| -38% | -$390K | ﹤0.01% | 3466 |
|
|
2013
Q3 | $935K | Buy |
23,428
+3,725
| +19% | +$146K | ﹤0.01% | 3281 |
|
|
2013
Q2 | $701K | Buy |
+19,703
| New | +$754K | ﹤0.01% | 3362 |
|
Other funds holding HBIO
WN
SS
TRCT
BSC
PWMAI
Bank of New York Mellon's HBIO Position: Q2 2026 in Review
Bank of New York Mellon held its Harvard Bioscience (HBIO) position steady in Q2 2026 at 10,230 shares worth $62.9K. The position accounts for ﹤0.01% of the portfolio, ranked #4224.
Bank of New York Mellon first reported a position in HBIO in Q2 2013 and has held it in 53 quarters since. The position peaked at $1.75M in Q4 2021. 13 funds tracked by Wall St. Rank hold HBIO as of Q2 2026.
- Bank of New York Mellon held 10,230 shares of Harvard Bioscience worth $62.9K as of Q2 2026.
- Bank of New York Mellon left its Harvard Bioscience share count unchanged in Q2 2026.
- Harvard Bioscience made up ﹤0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #4224 holding.
- Bank of New York Mellon first reported a position in Harvard Bioscience in Q2 2013 and has held it in 53 quarters since.
- Bank of New York Mellon's Harvard Bioscience position peaked at $1.75M in Q4 2021.
- 13 funds tracked by Wall St. Rank held Harvard Bioscience as of Q2 2026.
Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.